Composition for stimulating insulin secretion from cells and use thereof

US10653732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10653732-B2
Application numberUS-201815935634-A
CountryUS
Kind codeB2
Filing dateMar 26, 2018
Priority dateMar 27, 2017
Publication dateMay 19, 2020
Grant dateMay 19, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a composition for stimulating insulin secretion from cells, the composition including a Hypoxylon truncatum extract or an active ingredient thereof, and a method of stimulating insulin secretion from cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of stimulating insulin secretion from cells, the method comprising contacting a composition or an extract with cells, wherein the composition comprises any stereoisomer selected from the group consisting of Formulae I, II, and III, a solvate or hydrate thereof, or a mixture thereof, or a physiologically acceptable salt thereof: wherein, in Formula I, II, and III, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H or (C 1 -C 6 )-alkyl, and the extract is a Hypoxylon sp. mushroom extract comprising any stereoisomer selected from the group consisting of Formulae I, II, and III, a solvate or hydrate thereof, or a mixture thereof, or a physiologically acceptable salt thereof: wherein, in Formula I, II, and III, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H or (C 1 - C 6 ) alkyl. 2. The method of claim 1 , wherein the contacting is to administer the composition or the extract to a subject. 3. The method of claim 1 , wherein the cells are pancreatic beta cells. 4. The method of claim 1 , wherein the method is to prevent or treat diabetes in the subject. 5. The method of claim 1 , wherein R 1 and R 5 are each independently H or (C 1 -C 6 )-alkyl, and R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H. 6. The method of claim 5 , wherein R 1 and R 5 are each independently H, methyl, or ethyl. 7. The method of claim 1 , wherein the compounds of Formula I, II, and III exist at a weight ratio of 1.0: 0.20 to 0.60: 0.50 to 1.00 in the composition. 8. The method of claim 1 , the composition further comprising an excipient or a carrier which is acceptable for use in pharmaceuticals or foods. 9. The method of claim 5 , wherein the composition is a pharmaceutical composition or a food composition. 10. The method of claim 4 , wherein the diabetes is type 1 or type 2 diabetes. 11. The method of claim 1 , the composition comprising a Hypoxylon sp. mushroom extract comprising any stereoisomer selected from the group consisting of Formulae I, II, and III, or a mixture thereof, or a physiologically acceptable salt thereof. 12. The method of claim 11 , wherein the extract is extracted by an extraction method comprising contacting Hypoxylon sp. mushroom with water, (C 1 -C 3 )-alcohol, or a mixture thereof. 13. The method of claim 12 , wherein the extract is obtained by fractionating the extract with a R 13 —COO—R 14 solvent, wherein R 13 and R 14 are each independently (C 1 -C 6 )-alkyl. 14. The method of claim 12 , wherein the extract is a fraction obtained by fractionating the extract with a (C 4 -C 12 )-alkane solvent to obtain a fraction, removing this fraction to obtain a residue, fractionating the residue with a R 13 —COO—R 14 solvent, wherein R 13 and R 14 is each independently (C 1 -C 6 )-alkyl, thereby obtained the fraction.

Assignees

Inventors

Classifications

  • A61K36/062Primary

    Ascomycota · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • for hyperglycaemia, e.g. antidiabetics · CPC title

  • Complex extraction schemes, e.g. fractionation or repeated extraction steps · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10653732B2 cover?
Provided are a composition for stimulating insulin secretion from cells, the composition including a Hypoxylon truncatum extract or an active ingredient thereof, and a method of stimulating insulin secretion from cells.
Who is the assignee on this patent?
Korea Inst Sci & Tech
What technology area does this patent fall under?
Primary CPC classification A61K36/062. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).